Spire Wealth Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Spire Wealth Management's AMED Position: Q3 2025 in Review
Spire Wealth Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 105 shares — an estimated $10.3K sold.
Spire Wealth Management first reported a position in AMED in Q1 2021 and held it in 18 quarters. The position peaked at $31K in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Spire Wealth Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Spire Wealth Management sold 105 Amedisys shares in Q3 2025, an estimated $10.3K.
- Spire Wealth Management first reported a position in Amedisys in Q1 2021 and held it in 18 quarters.
- Spire Wealth Management's Amedisys position peaked at $31K in Q2 2021.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Spire Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.